IFM Investors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.4M | Buy |
50,317
+1,781
| +4% | +$793K | 0.21% | 91 |
|
|
2025
Q1 | $23.5M | Sell |
48,536
-195
| -0.4% | -$94.5K | 0.26% | 80 |
|
|
2024
Q4 | $19.6M | Sell |
48,731
-4,691
| -9% | -$1.89M | 0.2% | 94 |
|
|
2024
Q3 | $24.8M | Sell |
53,422
-65
| -0.1% | -$30.2K | 0.24% | 78 |
|
|
2024
Q2 | $25.1M | Buy |
53,487
+1,034
| +2% | +$485K | 0.25% | 74 |
|
|
2024
Q1 | $21.9M | Sell |
52,453
-213
| -0.4% | -$89K | 0.24% | 80 |
|
|
2023
Q4 | $21.4M | Sell |
52,666
-277
| -0.5% | -$113K | 0.26% | 78 |
|
|
2023
Q3 | $18.4M | Buy |
52,943
+1,703
| +3% | +$592K | 0.24% | 82 |
|
|
2023
Q2 | $18M | Buy |
51,240
+4,102
| +9% | +$1.44M | 0.24% | 82 |
|
|
2023
Q1 | $14.9M | Buy |
47,138
+1,423
| +3% | +$448K | 0.23% | 89 |
|
|
2022
Q4 | $13.2M | Buy |
45,715
+1,184
| +3% | +$342K | 0.22% | 97 |
|
|
2022
Q3 | $12.9M | Buy |
44,531
+601
| +1% | +$174K | 0.23% | 86 |
|
|
2022
Q2 | $12.4M | Buy |
43,930
+2,199
| +5% | +$620K | 0.22% | 95 |
|
|
2022
Q1 | $10.9M | Buy |
41,731
+7,534
| +22% | +$1.97M | 0.17% | 117 |
|
|
2021
Q4 | $7.51M | Sell |
34,197
-403
| -1% | -$88.5K | 0.14% | 140 |
|
|
2021
Q3 | $6.28M | Buy |
34,600
+2
| +0% | +$363 | 0.13% | 150 |
|
|
2021
Q2 | $6.98M | Buy |
34,598
+5,776
| +20% | +$1.16M | 0.14% | 145 |
|
|
2021
Q1 | $6.19M | Buy |
28,822
+3,848
| +15% | +$827K | 0.17% | 126 |
|
|
2020
Q4 | $5.9M | Buy |
24,974
+2,997
| +14% | +$708K | 0.19% | 114 |
|
|
2020
Q3 | $5.98M | Buy |
21,977
+3,093
| +16% | +$842K | 0.25% | 77 |
|
|
2020
Q2 | $5.48M | Sell |
18,884
-6,591
| -26% | -$1.91M | 0.28% | 70 |
|
|
2020
Q1 | $5.91M | Sell |
25,475
-943
| -4% | -$219K | 0.26% | 84 |
|
|
2019
Q4 | $5.78M | Sell |
26,418
-1,178
| -4% | -$258K | 0.2% | 106 |
|
|
2019
Q3 | $4.68M | Buy |
27,596
+9,502
| +53% | +$1.61M | 0.17% | 135 |
|
|
2019
Q2 | $3.32M | Buy |
18,094
+1,229
| +7% | +$225K | 0.19% | 117 |
|
|
2019
Q1 | $3.1M | Buy |
16,865
+2,180
| +15% | +$401K | 0.2% | 110 |
|
|
2018
Q4 | $2.43M | Buy |
14,685
+1,330
| +10% | +$220K | 0.2% | 113 |
|
|
2018
Q3 | $2.57M | Buy |
13,355
+1,954
| +17% | +$377K | 0.2% | 113 |
|
|
2018
Q2 | $1.94M | Buy |
11,401
+3,525
| +45% | +$599K | 0.18% | 124 |
|
|
2018
Q1 | $1.28M | Buy |
7,876
+833
| +12% | +$136K | 0.18% | 128 |
|
|
2017
Q4 | $1.06M | Buy |
7,043
+42
| +0.6% | +$6.29K | 0.17% | 141 |
|
|
2017
Q3 | $1.06M | Buy |
7,001
+201
| +3% | +$30.5K | 0.18% | 134 |
|
|
2017
Q2 | $876K | Buy |
6,800
+1,811
| +36% | +$233K | 0.16% | 154 |
|
|
2017
Q1 | $546K | Buy |
4,989
+1,833
| +58% | +$201K | 0.14% | 178 |
|
|
2016
Q4 | $233K | Buy |
+3,156
| New | +$233K | 0.11% | 254 |
|